132 related articles for article (PubMed ID: 17936175)
21. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors.
Bucciarelli S; Cervera R; Espinosa G; Gómez-Puerta JA; Ramos-Casals M; Font J
Autoimmun Rev; 2006 Dec; 6(2):72-5. PubMed ID: 17138246
[TBL] [Abstract][Full Text] [Related]
22. European Forum on Antiphospholipid Antibodies: research in progress.
Meroni PL; Tincani A; Alarcón-Riquelme ME; Shoenfeld Y; Borghi MO
Lupus; 2009 Sep; 18(10):924-9. PubMed ID: 19671794
[TBL] [Abstract][Full Text] [Related]
23. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL
Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418
[TBL] [Abstract][Full Text] [Related]
24. Update on the catastrophic antiphospholipid syndrome and the "CAPS Registry".
Cervera R; Espinosa G
Semin Thromb Hemost; 2012 Jun; 38(4):333-8. PubMed ID: 22618528
[TBL] [Abstract][Full Text] [Related]
25. European attempts for the standardisation of the antiphospholipid antibodies.
Tincani A; Filippini M; Scarsi M; Galli M; Meroni PL
Lupus; 2009 Sep; 18(10):913-9. PubMed ID: 19671792
[TBL] [Abstract][Full Text] [Related]
26. The clinical spectrum of antiphospholipid syndrome.
Baker WF; Bick RL
Hematol Oncol Clin North Am; 2008 Feb; 22(1):33-52, v-vi. PubMed ID: 18207064
[TBL] [Abstract][Full Text] [Related]
27. Management of antiphospholipid syndrome.
Tuthill JI; Khamashta MA
J Autoimmun; 2009 Sep; 33(2):92-8. PubMed ID: 19559568
[TBL] [Abstract][Full Text] [Related]
28. Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome.
Forastiero R; Martinuzzo M
Lupus; 2008 Oct; 17(10):872-7. PubMed ID: 18827051
[TBL] [Abstract][Full Text] [Related]
29. Antiphospholipid syndrome (APS): where does it come from?
Sherer Y; Blank M; Shoenfeld Y
Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):1071-8. PubMed ID: 18068862
[TBL] [Abstract][Full Text] [Related]
30. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
31. New targeted therapies for treatment of thrombosis in antiphospholipid syndrome.
Pierangeli SS; Vega-Ostertag ME; González EB
Expert Rev Mol Med; 2007 Nov; 9(30):1-15. PubMed ID: 17997880
[TBL] [Abstract][Full Text] [Related]
32. Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients.
García-Carrasco M; Galarza C; Gómez-Ponce M; Cervera R; Rojas-Rodríguez J; Espinosa G; Bucciarelli S; Gómez-Puerta JA; Bové A; Escárcega RO; Font J
Lupus; 2007; 16(5):366-73. PubMed ID: 17576741
[TBL] [Abstract][Full Text] [Related]
33. Autoantibody explosion in antiphospholipid syndrome.
Shoenfeld Y; Twig G; Katz U; Sherer Y
J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
[TBL] [Abstract][Full Text] [Related]
34. Pregnancy outcome in systemic lupus erythematosus complicated by anti-phospholipid antibodies.
Mecacci F; Bianchi B; Pieralli A; Mangani B; Moretti A; Cioni R; Giorgi L; Mello G; Matucci-Cerinic M
Rheumatology (Oxford); 2009 Mar; 48(3):246-9. PubMed ID: 19109318
[TBL] [Abstract][Full Text] [Related]
35. Antiphospholipid syndrome in children.
Avcin T
Curr Opin Rheumatol; 2008 Sep; 20(5):595-600. PubMed ID: 18698184
[TBL] [Abstract][Full Text] [Related]
36. [Antiphospholipid antibodies with HCV infection. Innocent proteins or risk factor?].
Kisiel E; Kryczka W
Przegl Lek; 2007; 64(7-8):521-4. PubMed ID: 18409357
[TBL] [Abstract][Full Text] [Related]
37. Anti-phospholipid syndrome: clinical spectrum and therapeutical/prophylactic strategies in the pediatric population.
Rigante D; Gaspari S; Bersani G; Stabile A
Eur Rev Med Pharmacol Sci; 2008; 12(1):47-53. PubMed ID: 18401972
[TBL] [Abstract][Full Text] [Related]
38. Pediatric APS: State of the Art.
Soybilgic A; Avcin T
Curr Rheumatol Rep; 2020 Mar; 22(3):9. PubMed ID: 32124078
[TBL] [Abstract][Full Text] [Related]
39. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
40. Clinical manifestations and outcomes of antithrombotic treatment of the Tan Tock Seng Hospital Singapore antiphospholipid syndrome cohort.
Tan BE; Thong BY; Shivananda S; Han WW; Chng HH
Lupus; 2009 Jul; 18(8):752-8. PubMed ID: 19502274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
